Core Insights - 40 Brightwater LLC executed a Sales Purchase Agreement for $10 billion worth of Bitcoin at a 90% Discount / 90% Premium, allowing significant leverage with PEG Global Private Equity X S.A.SICAV-RAIF's Cryptocurrency Lender [1] - A Letter of Intent was signed for a 10-year loan of $21 billion, secured by standby letters of credit from a top 10 European Bank and a $100 million deposit into Oaktree Capital's Escrow, with closing scheduled for October 31, 2025 [2] - Multicorp International, Inc. will receive $10 billion from the $21 billion loan to 40 Brightwater LLC, enhancing its business capabilities and alliances [3] Company Overview - Multicorp International, Inc. is a diversified leader in health, energy, and agriculture, focusing on strategic initiatives for growth and market expansion [4] - Partners Global Equity Group manages $95 billion in assets and is a major player in private equity, venture capital, and credit, providing transformational capital and expertise [5] - Airavata Developers Corporation specializes in commercial and industrial infrastructure construction, emphasizing project management and sustainability [6] - Edwards Capital N.A. LLC is a private Family Office focused on enhancing private wealth through strategic asset class initiatives [7] - 40 Brightwater LLC is a private holding company that acquires private entities and merges them with public companies, leveraging its financial network [8]

Track Bitmine’s recent acquisitions in this custom entity:https://t.co/SdylbrJYWF ...

Core Viewpoint - Sandstorm Gold Ltd. has completed its arrangement with Royal Gold, Inc., resulting in Royal Gold acquiring all outstanding common shares of Sandstorm [1][2]. Summary by Sections Arrangement Details - Sandstorm shareholders received 0.0625 of a share of Royal Gold for each Sandstorm Share held as part of the arrangement [2]. - The Sandstorm Shares are expected to be delisted from both the Toronto Stock Exchange and the New York Stock Exchange within two to three business days following the announcement [3]. - Sandstorm will apply to cease being a reporting issuer in applicable jurisdictions and will deregister its shares under the U.S. Securities Exchange Act of 1934 [3]. Shareholder Instructions - Shareholders are advised to review the Management Information Circular dated September 8, 2025, for details on receiving the consideration for their shares [4][5]. - Registered shareholders must complete and return the letter of transmittal along with their share certificates to Computershare Investor Services Inc. [5]. - Non-registered shareholders should contact their intermediaries for instructions on receiving the consideration [5]. Additional Information - Due to the ongoing Canada Post strike, registered shareholders are encouraged to use courier services or hand deliver their documentation to the depositary [6].

Core Insights - Arthur J. Gallagher & Co. has acquired Strategic Services Group, Inc., a Michigan-based employee benefits consulting firm, although the terms of the transaction were not disclosed [1][2]. Company Overview - Strategic Services Group specializes in employee benefits consulting services across various industries in Michigan and the Midwest [2]. - The team led by Doug Roehm and Greg Sudderth will continue to operate from their current location under the leadership of Brian Lomas, who oversees Gallagher's Great Lakes region employee benefits consulting and brokerage operations [2]. Strategic Implications - The acquisition is expected to enhance Gallagher's employee health benefits consulting capabilities in the region, as noted by J. Patrick Gallagher, Jr., Chairman and CEO [3]. - Gallagher operates globally, providing insurance brokerage, risk management, and consulting services in approximately 130 countries [3].

Core Points - Western Midstream Partners, LP has completed the acquisition of Aris Water Solutions, Inc, enhancing its position as a leading midstream flow-assurance provider in the Delaware Basin [2][3] - The merger allows Western Midstream to better address the challenges faced by producer customers in Texas and New Mexico regarding produced-water management [2] Acquisition Details - Each share of Aris Class A common stock and corresponding units was converted into either 0.625 common units of WES, $25.00 in cash, or a combination of 0.450 common units and $7.00 in cash [2][3] - Approximately 28% of the total merger consideration will be in cash, totaling $415.0 million, while about 72% will be in common units, amounting to approximately 26.6 million units [3] Company Overview - Western Midstream operates midstream assets across Texas, New Mexico, Colorado, Utah, and Wyoming, focusing on natural gas and produced water management [4] - The company’s cash flows are largely protected from commodity price volatility through fee-based contracts, providing stability in operations [4]

Tokio Marine, Japan’s top property and casualty insurer, could spend more than $10 billion on acquisitions to boost its international business, according to Brad Irick, who co-heads the unit https://t.co/MVcAJxKjRX ...

Group 1: Maple Leaf Foods and Canada Packers - Maple Leaf Foods retains a 16% stake in Canada Packers and has established an evergreen supply agreement, with Canada Packers serving as an anchor customer for Maple Leaf's prepared meats business [1] - Michael McCain, executive chair of both companies, emphasizes that they will operate as independent entities with distinct investment profiles and experienced teams [2] Group 2: TMX Group and Verity Acquisition - TMX Group has acquired U.S.-based data and analytics provider Verity, although financial terms of the agreement were not disclosed [3] - Verity offers two main products: VerityRMS, a research management system, and VerityData, which provides enhanced data sets focused on public equity filings [3][4] - The acquisition is expected to strengthen TMX Group's ability to serve a growing global client base [4] Group 3: MEG Energy and Cenovus Offer - MEG Energy reports that Glass Lewis has recommended its shareholders support the takeover offer from Cenovus Energy, following a similar recommendation from Institutional Shareholder Services [8][9] - The Cenovus offer requires a two-thirds majority vote from MEG shareholders, with the vote scheduled for October 9 [9] - Strathcona Resources intends to vote against the Cenovus deal, holding a 14.2% interest in MEG [9][10] Group 4: Stella-Jones Acquisition of Brooks Manufacturing - Stella-Jones has signed a deal to acquire Brooks Manufacturing for US$140 million, enhancing its product offerings in treated wood distribution [11][12] - The acquisition aligns with Stella-Jones' strategic focus on meeting the growing demand from utilities and expanding its infrastructure segment [12][13] - Brooks' sales for 2024 are projected to be approximately US$84 million, and the deal is subject to regulatory approval [12][13]

Core Insights - PPG Industries is navigating challenges from demand weakness, particularly in Europe, while benefiting from cost discipline, acquisitions, and pricing actions [1] Cost Management and Restructuring - PPG is implementing a cost-cutting and restructuring strategy, focusing on regions and end markets with weak business conditions, realizing an additional $20 million in structural cost savings in Q2 2025, and expecting around $60 million in restructuring savings for the full year 2025 [2][9] - A comprehensive cost reduction program is expected to deliver annualized pre-tax savings of approximately $175 million once fully implemented, primarily targeting structural costs in Europe and other global businesses [3][9] Acquisitions and Growth Strategy - The company is pursuing inorganic growth through value-creating acquisitions, with contributions from acquisitions like Tikkurila, Worwag, Cetelon, and Arsonsisi's powder coatings business expected to enhance its top line [4][9] Financial Performance and Shareholder Returns - PPG has a strong track record of returning cash to shareholders, having returned $1.4 billion in 2024 through dividends and share repurchases, including $620 million in dividends and $750 million in share buybacks [5] - The company raised its quarterly dividend by 4% in July 2025, reflecting robust financial performance with operating cash flow reaching around $1.4 billion in 2024 [5] Market Challenges - PPG faces challenges from soft global industrial production, impacting demand in the Industrial Coatings segment, with lower automotive OEM build rates and weak consumer confidence in Europe contributing to reduced volumes and sales [6][8] - Overall organic growth is expected to be limited due to these factors, with industrial coatings demand anticipated to remain under pressure in the third quarter [7][9] Earnings Guidance - PPG maintained its full-year 2025 adjusted earnings per share guidance of $7.75 to $8.05, supported by continued share gains and internal improvement initiatives while considering current global economic conditions [9]

Core Viewpoint - Pfizer is transitioning towards a new era of growth after experiencing significant revenue from coronavirus-related products, but is now facing challenges due to declining sales and upcoming patent expirations [1][2]. Revenue and Financial Performance - Pfizer achieved over $100 billion in annual revenue in 2022, primarily driven by its coronavirus products, but is now realigning costs to match future revenue opportunities, aiming for over $7 billion in cost savings by 2027 [4]. - The company has seen its stock decline nearly 30% over the past five years due to concerns over patent expirations for key products [2][5]. Product Pipeline and Growth Strategy - Pfizer is preparing for the loss of exclusivity on four major drugs, including Eliquis and Ibrance, which could lead to revenue declines [5]. - The company has launched a significant number of new products, predicting that these could generate $20 billion in revenue by 2030, with recent launches contributing $4.7 billion [7][9]. - Pfizer's acquisition of Seagen is expected to enhance its oncology portfolio, with projections of $10 billion in revenue from Seagen's drugs by 2030 [8]. Research and Development Focus - Pfizer is reinvesting savings from its cost realignment into R&D to support ongoing programs and maintain a robust pipeline [8]. - The company aims to achieve over $80 billion in non-coronavirus product revenues by 2030, up from approximately $63 billion last year [9]. Future Outlook - Despite facing hurdles from patent expirations, Pfizer's strategic initiatives are expected to yield new growth opportunities, with the potential for new blockbuster drugs to drive revenue gains in the coming years [10].

here. Veto Sperudo is here. Veto, good to have you on.Really appreciate you joining us. Thank you very much. >> Thank you for having me.I think I'm going to bring you out to like hype me up like that every time. >> That was good, right. Let's get ready to rumble.But you would note that unfortunately I've got to temper those numbers a little bit because those numbers are for the big big deals. Are deals under a billion dollars getting any traction. >> Yeah, I mean as you noted, deals over five billion are up ...